The regulation of T-cell cytokine production by ICOS-B7H2 interactions at the human fetomaternal interface

Immunology and Cell Biology

Volumn 89, Issue 3, 2011, Pages 417-425

  Nagamatsu, Takeshi ^a   Barrier, Breton F ^a   Schust, Danny J ^a  

^a University of Missouri   (United States)

Author keywords

decidua; inducible costimulator; pregnancy; T cells; trophoblast

Indexed keywords

B7H2; CD4 ANTIGEN; CD45RA ANTIGEN; CD45RO ANTIGEN; CD8 ANTIGEN; CYTOKINE; GAMMA INTERFERON; INDUCIBLE COSTIMULATOR; INTERLEUKIN 10; LIGAND; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; T LYMPHOCYTE RECEPTOR; TRANSCRIPTION FACTOR FOXP3; UNCLASSIFIED DRUG;

ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL COMMUNICATION; CELL CULTURE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DECIDUA; ENZYME LINKED IMMUNOSORBENT ASSAY; FETOPLACENTAL UNIT; FLOW CYTOMETRY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPHOCYTE FUNCTION; LYMPHOCYTE SUBPOPULATION; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; REGULATORY T LYMPHOCYTE; T LYMPHOCYTE; TROPHOBLAST;

ANTIGENS, CD; ANTIGENS, DIFFERENTIATION, T-LYMPHOCYTE; CELL LINE; CYTOKINES; DECIDUA; FEMALE; HUMANS; PREGNANCY; PROTEIN BINDING; T-LYMPHOCYTE SUBSETS; T-LYMPHOCYTES; T-LYMPHOCYTES, REGULATORY; TROPHOBLASTS;

EID: 79952818553     PISSN: 08189641     EISSN: 14401711     Source Type: Journal    
DOI: 10.1038/icb.2010.101     Document Type: Article

References (49)

1. Lockwood CJ. Recent advances in elucidating the pathogenesis of preterm delivery, the detection of patients at risk, and preventative therapies. Curr Opin Obstet Gynecol 1994; 6: 7-18. (Pubitemid 24052441)
2. Szekeres-Bartho J. Immunological relationship between the mother and the fetus. Int Rev Immunol 2002; 21: 471-495. (Pubitemid 35399954)
3. Williams PJ, Searle RF, Robson SC, Innes BA, Bulmer JN. Decidual leucocyte populations in early to late gestation normal human pregnancy. J Reprod Immunol 2009; 82: 24-31.
4. Lenschow DJ, Walunas TL, Bluestone JA. CD28/B7 system of T cell costimulation. Annu Rev Immunol 1996; 14: 233-258. (Pubitemid 26130184)
5. Hutloff A, Dittrich AM, Beier KC, Eljaschewitsch B, Kraft R, Anagnostopoulos I et al. ICOS is an inducible T-cell co-stimulator structurallyand functionally related to CD28. Nature 1999; 397: 263-266.
6. Yoshinaga SK, Whoriskey J, Khare SD, Sarmiento U, Guo J, Horan T et al. T-cell co-stimulationthrough B7RP-1 and ICOS. Nature 1999; 402: 827-832.
7. Ling V, Wu P, Finnerty HF, Bean KM, Spaulding V, Fouser LA et al. Cutting edge: identification of GL50, a novel B7-like protein that functionally binds to ICOS receptor. J Immunol 2000; 164: 1653-1657. (Pubitemid 30108711)
8. Coyle AJ, Lehar S, Lloyd C, Tian J, Delaney T, Manning S et al. The CD28-related molecule ICOS is required for effective Tcell-dependent immune responses. Immunity 2000; 13: 95-105.
9. Park H, Li Z, Yang XO, Chang SH, Nurieva R, Wang YH et al. A distinct lineage of CD4 Tcells regulates tissue inflammation by producing interleukin 17. Nat Immunol 2005; 6: 1133-1141. (Pubitemid 41541791)
10. Harada Y, Ohgai D, Watanabe R, Okano K, Koiwai O, Tanabe K et al. Asingleamino acid alteration in cytoplasmic domain determines IL-2 promoter activation by ligation of CD28 but not inducible costimulator (ICOS). J Exp Med 2003; 197: 257-262. (Pubitemid 36152319)
11. Riley JL, Blair PJ, Musser JT, Abe R, Tezuka K, Tsuji T et al. ICO Scostimulation requires IL-2 and can be prevented by CTLA-4 engagement. J Immunol 2001; 166: 4943-4948. (Pubitemid 32280704)
12. + effector T cells with high inflammatory potential and a strong bias for secretion of interleukin 10. J Exp Med 2003; 197: 181-193. (Pubitemid 36152313)
13. Tafuri A, Shahinian A, Bladt F, Yoshinaga SK, Jordana M, Wakeham A et al. ICOS is essential for effective T-helper-cell responses. Nature 2001; 409: 105-109. (Pubitemid 32098634)
14. Warnatz K, Bossaller L, Salzer U, Skrabl-Baumgartner A, Schwinger W, van der Burg M et al. Human ICOS deficiency abrogates the germinal center reaction and provides a monogenic model for common variable immunodeficiency. Blood 2006; 107: 3045-3052.
15. Petroff MG, Chen L, Phillips TA, Azzola D, Sedlmayr P, Hunt JS. B7 family molecules are favorably positioned at the human maternal-fetal interface. Biol Reprod 2003; 68: 1496-1504. (Pubitemid 36519751)
16. Petroff MG, Kharatyan E, Torry DS, Holets L. The Immunomodulatory proteins B7-DC, B7-H2, and B7-H3 aredifferentiallyexpressed acrossgestation in thehuman placenta. Am J Pathol 2005; 167: 465-473. (Pubitemid 43026102)
17. Takahashi T, Tagami T, Yamazaki S, Uede T, Shimizu J, Sakaguchi N et al. Immunologic self-tolerance maintained by CD25(+)CD4(+) regulatory T cells constitutively expres-sing cytotoxic T lymphocyte-associated antigen 4. J Exp Med 2000; 192: 303-310.
18. + regulatory T cells in early pregnancy subjects and spontaneous abortion cases. Mol Hum Reprod 2004; 10: 347-353. (Pubitemid 38714366)
19. Keir ME, Butte M, Freeman GJ, Sharpe AH. PD-1 and its ligands in tolerance and immunity. Ann Rev Immunol 2008; 26: 677-704. (Pubitemid 351600389)
20. Guleria I, Khosroshahi A, Ansari MJ, Habicht A, Azuma M, Yagita H et al. Acritical role fortheprogrammeddeath ligand 1 infetomaternaltolerance. J Exp Med 2005; 202: 231-237. (Pubitemid 41043819)
21. Nurieva RI. Regulation of immune and autoimmune responses by ICOS-B7h interaction. Clin Immunol 2005; 115: 19-25. (Pubitemid 40616164)
22. Margott-Procelewska M. Costimulatory pathways as a basic mechanism of activating a tolerance signal in Tcells. Ann Transplant 2004; 9: 13-18.
23. Zenclussen AC, Gerlof K, Zenclussen ML, Ritschel S, Zambon Bertoja A, Fest S et al. Regulatory Tcells induce a privileged tolerant microenvironment at the fetal-maternal interface. Eur J Immunol 2006; 36: 82-94. (Pubitemid 43116395)
24. Ramsdell F. Foxp3 and natural regulatory T cells: keytoa cell lineage? Immunity 2003; 19: 165-168. (Pubitemid 37011331)
25. Kovats S, Main E, Librach C, Stubblebine M, Fisher SJ, DeMars R. A class I antigen, HLA-G, expressed in human trophoblasts. Science 1990; 248: 220-223. (Pubitemid 120031455)
26. Aicher A, Hayden-Ledbetter M, Brady WA, Pezzutto A, Richter G, Magaletti D et al. Characterization of human iducible costimulator ligand expression and function. J Immunol 2000; 164: 4689-4696. (Pubitemid 30238069)
27. Yamazaki T, Akiba H, Iwai H, Matsuda H, Aoki M, Tanno Y et al. Expression of programmed death 1 ligands by murine T cells and APC J Immunol 2002; 169: 5538-5545. (Pubitemid 35291652)
28. Vieira PL, Wassink L, Smith LM, Nam S, Kingsbury GA, Gutierrez-Ramos JC et al. ICOS-mediated signalingregulatescytokineproduction byhumanTcellsand providesa unique signal to selectively control the clonal expansion of Th2 helper cells. Eur J Immunol 2004; 34: 1282-1290. (Pubitemid 39256007)
29. Slukvin II, Merkulova A, Vodyanik MA, Chernyshov VP. Differential expression of CD45RA and CD45RO molecules on human decidual and peripheral blood lympho-cytes at early stage of pregnancy. Am J Reprod Immunol 1996; 35: 16-22. (Pubitemid 26028106)
30. Strauss L, Bergmann C, Szczepanski MJ, Lang S, Kirkwood JM, Whiteside TL. Expression of ICOS on human melanoma-infiltrating CD4+CD25highFoxp3+ T regulatory cells: implications and impact on tumor-mediated immune suppression. J Immunol 2008; 180: 2967-2980.
31. Yoshinaga SK, Zhang M, Pistillo J, Horan T, Khare SD, Miner K et al. Characterizationof a new human B7-related protein: B7RP-1 is the ligand to the co-stimulatory protein ICOS. Int Immunol 2000; 12: 1439-1447.
32. Wahl P, Schoop R, Bilic G, Neuweiler J, Le Hir M, Yoshinaga SK et al. Renal tubular epithelial expression of the costimulatory molecule B7RP-1 (inducible costimulator ligand). J Am Soc Nephrol 2002; 13: 1517-1526. (Pubitemid 34579241)
33. Qian X, Agematsu K, Freeman GJ, Tagawa Y, Sugane K, Hayashi T. The ICOS-ligand B7-H2, expressed on human type II alveolar epithelial cells, plays a role in the pulmonary host defense system. Eur J Immunol 2006; 36: 906-918.
34. Gotsch F, Romero R, Kusanovic JP, Erez O, Espinoza J, Kim CJ et al. The anti-inflammatory limb of the immune response in preterm labor, intra-amniotic infection/inflammation, and spontaneous parturition at term: A role for interleukin-10. J Matern Fetal Neonatal Med 2008; 21: 529-547.
35. Ashkar AA, Di Santo JP, Croy BA. Interferon-γ contributes to initiation of uterine vascular modification, decidual Integrity, and uterine natural killer cell maturation during normal murine pregnancy J Exp Med 2000; 192: 259-270.
36. bright natural killer cells in the human early pregnancy decidua. Int Immunol 1993; 5: 559-563. (Pubitemid 23162525)
37. O'neill EJ, Sundstedt A, Mazza G, Nicolson KS, Ponsford M, Saurer L et al. Natural and induced regulatoryTcells. Ann NY Acad Sci 2004; 1029: 180-192.
38. Tuettenberg A, Huter E, Hubo M, Horn J, Knop J, Grimbacher B et al. The role of ICOS in directing Tcell responses: ICOS-dependent induction of Tcell anergy bytolerogenic dendritic cells. J Immunol 2009; 182: 3349-3356.
39. Lala PK, Scodras JM, Graham CH, Lysiak JJ, Parhar RS. Activation of maternal killer cells in the pregnant uterus with chronic indomethacin therapy, IL-2 therapy, or a combination therapy is associated with embryonic demise. Cell Immunol 1990; 127: 368-381. (Pubitemid 20147795)
40. Hara N, Fujii T, Okai T, Taketani Y Histochemical demonstration of interleukin-2 in decidua cells of patientswith preeclampsia. Am J Reprod Immunol 1995; 34: 44-51.
41. Kilani RT, Mackova M, Davidge ST, Guilbert LJ. Effect of oxygen levels in villous trophoblastapoptosis. Placenta 2003; 24: 826-834. (Pubitemid 37184810)
42. Ishitani A, Sageshima N, Lee N, Dorofeeva N, Hatake K, Marquardt H et al. Protein expression and peptide binding suggest unique and interacting functional roles for HLA-E, F, and G in maternal-placental immune recognition. J Immunol 2003; 171: 1376-1384. (Pubitemid 36900070)
43. King A, Boocock C, Sharkey AM, Gardner L, Beretta A, Siccardi AG et al. Evidence for the expression of HLAA-C class I mRNA and protein by human first trimester trophoblast. J Immunol 1996; 156: 2068-2076. (Pubitemid 26087436)
44. Hunt JS, Petroff MG, McIntire RH, Ober C. HLA-G and immunetolerance in pregnancy. FASEBJ2005; 19: 681-693.
45. Fournel S, Aguerre-Girr M, Huc X, Lenfant F, Alam A, Toubert A et al. Cutting edge: soluble HLA-G1 triggers CD95/CD95 ligand-mediated apoptosis in activated CD8+ cells by interacting with CD8. J Immunol 2000; 164: 6100-6104. (Pubitemid 30408785)
46. Mazzarino P, Pietra G, Vacca P, Falco M, Colau D, Coulie P et al. Human Tcell receptor-mediated recognition of HLA-E. Eur J Immunol 2002; 32: 936-944.
47. Romagnani C, Pietra G, Falco M, Mazzarino P, Moretta L, Mingari MC. HLA-E-restricted recognition of human cytomegalovirus by a subset of cytolytic T lymphocytes. Hum Immunol 2004; 65: 437-445. (Pubitemid 38686768)
48. Tilburgs T, Roelen DL, van der Mast BJ, van Schip JJ, Kleijburg C, deGroot-Swings GM et al. Differential distribution of CD4(+)CD25(bright) and CD8(+)CD28(-) T-cells in decidua and maternal blood during human pregnancy. Placenta 2006; 27: S47-S53.
49. Youngnak-Piboonratanakit P, Tsushima F, Otsuki N, Igarashi H, Omura K, Azuma M. Expression and regulation of human CD275 on endothelial cells in healthy and inflamed mucosal tissues. Scand J Immunol 2006; 63: 191-198. (Pubitemid 43356780)